Abstract
The current WHO classification of mastocytosis defines one major and four minor diagnostic criteria for systemic mastocytosis (SM). One of the minor criteria is the detection of the “gain-of-function” mutation D816V of the c-kit proto-oncogene in extracutaneous organs. The receptor molecule KIT is a potential therapeutic target for tyrosine kinase inhibitors. KIT mutations have been described in more than 80% of SM, but only in the minority of cutaneous mastocytoses (CM). Usually exon 17 amplicons generated by polymerase chain reaction are analyzed for the detection of c-kit mutations. Most frequently the method of restriction fragment length polymorphism (RFLP) analysis using the endonuclease Hinf I is used. Another well-established technique utilizes melting point analysis of amplification products with specific hybridization probes. Recently, also allele-specific PCR assays have been described. The technique used for the detection of c-kit mutations in mastocytosis is dependent on the kind of material to be analyzed and the laboratory equipment available. In this chapter the techniques of PNA-mediated PCR-clamping in combination with melting point analysis for the genotyping of amplification products are described for mutational analysis in total DNA and microdissected cells from formalin-fixed paraffin-embedded bone marrow trephine biopsies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Valent P, Horny H-P, Li CY, Longley BJ, Metcalfe DD, Parwaresch RM et al (2001) Mastocytosis (Mast cell disease). In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) World Health Organization (WHO) classification of tumours, pathology & genetics. Tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 291–302
Horny H-P, Metcalfe DD, Bennett JM, Bain BJ, Akin C, Escribano L et al (2008) Mastocytosis (Mast cell disease). In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Geneva, Switzerland, pp 54–63
Stein DH (1986) Mastocytosis: a review. Pediatr Dermatol 3:365–375
Lennert K, Parwaresch MR (1979) Mast cells and mast cell neoplasia: a review. Histopathology 3:349–365
Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ et al (1987) Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341–3351
Qiu FH, Ray P, Brown K, Barker PE, Jhanwar S, Ruddle FH et al (1988) Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family–oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 7:1003–1011
Ashman LK, Cambareri AC, To LB, Levinsky RJ, Juttner CA (1991) Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 78:30–37
Papayannopoulou T, Brice M, Broudy VC, Zsebo KM (1991) Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile. Blood 78:1403–1412
Reisbach G, Bartke I, Kempkes B, Kostka G, Ellwart J, Birner A et al (1993) Characterization of hemopoietic cell populations from human cord blood expressing c-kit. Exp Hematol 21:74–79
Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S, Kunisada T, Sudo T et al (1991) Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 174:63–71
Orr-Urtreger A, Avivi A, Zimmer Y, Givol D, Yarden Y, Lonai P (1990) Developmental expression of c-kit, a proto-oncogene encoded by the W locus. Development 109:911–923
Manova K, Nocka K, Besmer P, Bachvarova RF (1990) Gonadal expression of c-kit encoded at the W locus of the mouse. Development 110:1057–1069
Koch CA, Anderson D, Moran MF, Ellis C, Pawson T (1991) SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 3:668–674
Pawson T (1995) Protein-tyrosine kinases. Getting down to specifics [news; comment]. Nature 373:477–478
Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U et al (1993) Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92:1736–1744
Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H et al (1995) Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85:790–798
Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D et al (2004) KIT mutations are common in testicular seminomas. Am J Pathol 164:305–313
Gari M, Goodeve A, Wilson G, Winship P, Langabeer S, Linch D et al (1999) c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia. Br J Haematol 105:894–900
Andersson J, Sjogren H, Meis-Kindblom JM, Stenman G, Aman P, Kindblom LG (2002) The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors. Am J Pathol 160:15–22
Hongyo T, Li T, Syaifudin M, Baskar R, Ikeda H, Kanakura Y et al (2000) Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan. Cancer Res 1:2345–2347
Kong Y, Si L, Zhu Y, Xu X, Corless CL, Flaherty KT, Li L, Li H, Sheng X, Cui C, Chi Z, Li S, Han M, Mao L, Lu A, Guo J (2011) Large-scale analysis of KIT aberrations in Chinese patients with melanoma. Clin Cancer Res 17:1684–1691
Orum H, Nielsen PE, Egholm M, Berg RH, Buchardt O, Stanley C (1993) Single base pair mutation analysis by PNA directed PCR clamping. Nucleic Acids Res 21:5332–5336
Thiede C, Bayerdorffer E, Blasczyk R, Wittig B, Neubauer A (1996) Simple and sensitive detection of mutations in the ras proto-oncogenes using PNA-mediated PCR clamping. Nucleic Acids Res 24:983–984
Behn M, Thiede C, Neubauer A, Pankow W, Schuermann M (2000) Facilitated detection of oncogene mutations from exfoliated tissue material by a PNA-mediated ‘enriched PCR’ protocol. J Pathol 190:69–75
Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ (1997) The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22:176–181
Mangasser-Stephan K, Tag C, Reiser A, Gressner AM (1999) Rapid genotyping of hemochromatosis gene mutations on the LightCycler with fluorescent hybridization probes. Clin Chem 45:1875–1878
Elenitoba-Johnson KS, Bohling SD, Wittwer CT, King TC (2001) Multiplex PCR by multicolor fluorimetry and fluorescence melting curve analysis. Nat Med 7:249–253
Sotlar K, Escribano L, Landt O, Möhrle S, Herrero S, Torrelo A et al (2003) One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol 162:737–746
Horny HP, Sotlar K, Sperr WR, Valent P (2004) Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol 57:604–608
Sotlar K, Bache A, Stellmacher F, Bültmann B, Valent P, Horny HP (2008) Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a clonal hematological non-mast cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. J Mol Diagn 10:58–66
Sotlar K, Colak S, Bache A, Berezowska S, Krokowski M, Bültmann B et al (2010) Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD). J Pathol 220:586–595
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Sotlar, K. (2013). c-kit Mutational Analysis in Paraffin Material. In: Czader, M. (eds) Hematological Malignancies. Methods in Molecular Biology, vol 999. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-357-2_4
Download citation
DOI: https://doi.org/10.1007/978-1-62703-357-2_4
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-356-5
Online ISBN: 978-1-62703-357-2
eBook Packages: Springer Protocols